List Labs Bacterial Toxin & Vaccine Research Blog

Open Letter: Our Reflections From the 2016 BIO International Convention

June 14, 2016

By: douano@listlabs.com

By: Debra Booth, VP of Operations Linda Eaton, Ph.D., VP of Research & Development Stacy Burns-Guydish, Ph.D., Senior Director of Microbiology PJ Nehil, Sales & Distribution Coordinator Dear Researchers Everywhere, List Labs recently exhibited at the 2016 BIO International Convention. As a producer of bacterial products for research, as well as a provider of custom […]

Read more

Tetanus Toxin, a Vaccine Adjuvant and More

June 7, 2016

By: douano@listlabs.com

By: Dom C. Ouano, Marketing Coordinator Since List Labs introduced products in the Tetanus Toxin family more than 25 years ago, interest and knowledge in this field has multiplied. Tetanus Toxin C fragment, the non-toxic C-terminal domain of the heavy chain, is retrogradely transported to the central nervous system and is useful as a neuronal […]

Read more

C. septicum alpha toxin: Importance and applications in infectious disease and cancer research

May 16, 2016

By: douano@listlabs.com

UPDATE: July 13, 2016 Alpha Toxin from C. septicum, product #116L is now available for purchase online. Information on other potential upcoming products can be found on our Product Pipeline. UPDATE: May 16, 2016 Alpha Toxin from C. septicum is currently in late to final stages of development, and we are accepting orders now. We expect to ship […]

Read more

Open Letter: Translational Microbiome Conference 2016

April 26, 2016

By: douano@listlabs.com

By: Karen Crawford, Ph.D., President Dear Microbiome Researchers, I just returned from the Second Annual Translational Microbiome Conference in Boston and my head is spinning with the possibilities. Suggested connections between the microbial community living on/in our bodies and health are expanding from the health of our gut to asthma and beyond. Many in the field […]

Read more

Diphtheria Toxin for Cell Ablation

April 25, 2016

By: douano@listlabs.com

By: Karen Crawford, Ph.D., President In 1983, List Labs introduced Diphtheria Toxin to the research community. Researchers have purchased Diphtheria Toxin for various uses. One common use is cell ablation. The receptor for Diphtheria Toxin is also called heparin-binding EGF-like growth factor (HB-EGF). This receptor, located on several cell types, binds Diphtheria Toxin, allowing the toxin to enter […]

Read more

Jump At The Chance To Meet List Labs At Translational Microbiome 2016!

April 11, 2016

By: douano@listlabs.com

Dr. Karen Crawford, President of List Biological Laboratories, Inc. We will be exhibiting at the 2nd Annual Translational Microbiome Conference at the Hilton Boston Back Bay on April 20-21. We are also proud to be a sponsor of this event. If you will be in attendance, stop by the List Labs booth and chat with Karen Crawford about […]

Read more